medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2017, Number 1

<< Back

Arch Neurocien 2017; 22 (1)

Dopamina para principiantes

Avila-Rojas H, Pérez-Neri I

Language: Spanish
References: 13
Page: 55-57
PDF size: 144.80 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Lands AM, Nash VL. The pharmacology of compounds structurally related to hydroxytyramine. J Pharmacol Exp Ther. 1948 Apr;92(4):369–80.

  2. Gallardo AM. El cielo en el cerebro: la fascinante relación entre la Luna y los neurotransmisores [Internet]. PIJAMASURF.COM. [cited 2016 Jul 30]. Available from: http://pijamasurf.com/2015/04/el-cielo-en-el-cerebro-la-fascinante-relacion-entre-la-luna-y-los-neurotransmisores/

  3. The Rise and Fall of Neurotransmitters [Internet]. Neuroskeptic. 2015 [cited 2016 Jul 30]. Available from: http://blogs.discovermagazine.com/neuroskeptic/2015/08/15/the-rise-and-fall-of-neurotransmitters/

  4. Kumar AM, Fernández JB, González L, Kumar M. Ultra micro quantification of dopamine and homovanillic acid in human brain tissue: quest for higher recovery and sensitivity with coularray HPLC-ECD system. J Liquid Chromatogr Relat Technol 2006; 29: 777–799.

  5. Pérez-Neri I, Chávez E, Soltero M. Efecto de la DHEA sobre el metabolismo cerebral de la dopamina: Hormonas, estado de ánimo y muerte neuronal [Internet]. Saarbrücken: Editorial Académica Espańola; 2015 [cited 2015 Sep 14]. Available from: http://nbn-resolving.de/urn:nbn:de:101:1-2015062416146

  6. Bahena RT, Flores G, Arias JAM. Dopamina: síntesis, liberación y receptores en el sistema nervioso central. Rev Biomed 2000; 11: 39-60.

  7. Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 2011; 508: 1-12.

  8. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2011; 22(6):724-63.

  9. Chen L, Zhuang X. Transgenic mouse models of dopamine deficiency. Ann Neurol. 2003; 54(Suppl 6):S91-S102.

  10. Elsworth JD, Roth RH. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson’s disease. Exp Neurol 1997; 144: 4-9.

  11. Meiser J, Weindl D, Hiller K. Complexity of dopamine metabolism. Cell Commun Signal 2013; 11:34.

  12. Scott L, Aperia A. Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity. Neuroscience 2009; 158: 62-66.

  13. Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 2001; 13: 1071-1077.




2020     |     www.medigraphic.com